跳至主要内容
临床试验/IRCT20200708048060N1
IRCT20200708048060N1招募中2 期

Assessment of Gingko Biloba efficacy in treatment of drug-induced parkinsonism:; A randomized, double-blind, placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All psychiatric patients with the symptoms of drug induced parkinsonism, who have been given neurological counseling and Parkinson's drug-induced event has been confirmed based on clinical judgments and other findings among them
  • Age over 18 years

排除标准

  • Thrombocytopenia
  • Coagulopathy
  • Kidney failure
  • Liver failure
  • GI bleeding history
  • Consumption of warfarin, high dose NSAIDs or NSAIDS with SSRIs and CCBs.

研究者

相似试验